On 2025-11-13, Adial Pharmaceuticals, Inc. (ADIL) announced earnings per share of $-2.00 for the fiscal quarter ending 2025-09-30, beating the average analyst estimate of $-2.25.
The next expected annoucement date for quarterly earnings is 2026-03-10, with an average estimated earnings per share of $-2.10 for the fiscal quarter ending 2025-12-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-11-13 | 2025-09-30 | $-2.25 | $-2.00 |
| 2025-08-13 | 2025-06-30 | $-5.50 | $-4.50 |
| 2025-05-14 | 2025-03-31 | $-12.50 | $-8.50 |
| 2025-03-04 | 2024-12-31 | $-9.50 | $-3.75 |
| 2024-11-13 | 2024-09-30 | $-12.50 | $-9.50 |
| 2024-08-13 | 2024-06-30 | $-9.75 | $-14.75 |
| 2024-05-14 | 2024-03-31 | $-12.75 | $-17.00 |
| 2023-11-14 | 2023-09-30 | $-28.50 | $-28.50 |
| 2023-08-21 | 2023-06-30 | $-37.50 | $-33.25 |
| 2023-05-12 | 2023-03-31 | $-87.50 | $-68.75 |
| 2023-03-30 | 2022-12-31 | $-93.75 | $-68.75 |
| 2022-11-14 | 2022-09-30 | $-112.50 | $-75.00 |
| 2022-08-16 | 2022-06-30 | $-100.00 | $-100.00 |
| 2022-05-16 | 2022-03-31 | $-106.25 | $-81.25 |
| 2022-03-28 | 2021-12-31 | -- | $-175.00 |
| 2021-11-15 | 2021-09-30 | $-137.50 | $-137.50 |
| 2021-08-12 | 2021-06-30 | -- | $-156.25 |
| 2021-05-17 | 2021-03-31 | -- | $-187.50 |
| 2021-03-22 | 2020-12-31 | -- | $-150.00 |
| 2020-11-13 | 2020-09-30 | -- | $-150.00 |
| 2020-08-13 | 2020-06-30 | -- | $-100.00 |
| 2020-05-14 | 2020-03-31 | -- | $-137.50 |
| 2020-03-20 | 2019-12-31 | -- | $-118.75 |
| 2019-11-14 | 2019-09-30 | -- | $-106.25 |
| 2019-08-13 | 2019-06-30 | -- | $-131.25 |
| 2019-05-13 | 2019-03-31 | -- | $-206.25 |
| 2018-11-14 | 2018-09-30 | $-193.75 | $-531.25 |
| 2018-09-07 | 2018-06-30 | -- | $-312.50 |